Huntsman Cancer Institute at the University of Utah (the U) participated in a clinical trial that found that a new combination treatment plan helped people with recurring grade 3 astrocytoma, an aggressive form of brain cancer, live longer.
from Medical Xpress - latest medical and health news stories https://ift.tt/uEOFpDs
